News

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ...
Robitussin owes some cold sufferers money as part of a class-action settlement. The cough medicine brand has agreed to pay $4.5 million to resolve claims that it duped consumers by marketing its ...
Haleon, Robitussin’s manufacturer, denied any wrongdoing and agreed to the settlement to avoid legal expenses, according to the settlement website. The company did not respond to requests for ...
Buyers of Robitussin can now apply to get money from a class-action lawsuit that began in 2022 over the cough medicine being marketed as "non-drowsy." Consumers can get $1.50 to $4.75 per claim ...
Robitussin products are commonly used to treat cough and chest congestion. The main active ingredients in most products are guaifenesin and dextromethorphan Guaifenesin is an expectorant that ...
NEW YORK, July 22 (Reuters) - The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the ...
Robitussin is recalling several lots of its Honey cough syrups sold nationwide due to “microbial contamination,” according to the U.S. Food and Drug Administration. Robitussin’s parent ...
The U.S. Food and Drug Administration announced that Haleon, distributor of Robitussin cough syrup, issued a recall on two adult cough syrups. Eight lots of Robitussin Honey CF Max Day Adult and ...
On January 24, the U.S. Food and Drug Administration (FDA) announced that Haleon, the distributor of Robitussin cough syrup, issued a voluntary recall of eight lots of Robitussin Honey CF Max Day ...
WASHINGTON (AP) — The maker of Robitussin cough syrup is recalling several lots of products containing honey due to contamination that could pose a serious risk to people with weakened immune ...
Coming down with a cold this winter? Avoid using this recalled Robitussin medicine. The United States Food and Drug Administration announced on Jan. 24 that Haleon is voluntarily recalling eight ...